GlassScriptPhysician profile
Suraj Mishra
NPI 1184117657
$2,308.20
in general payments reported to CMS, 2019-2025
19 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $1,018 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,861 · Education: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,860.84 |
| Education | $447.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $517.31 | 2024-2025 | Diamondback Coronary, Dragonfly Opstar, Nc Trek Neo |
| Shockwave Medical, INC | $460.75 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $221.24 | 2024 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.81 | 2023-2025 | Lifevest |
| Abiomed | $162.17 | 2024 | Impella |
| Edwards Lifesciences Corporation | $162.12 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $99.69 | 2024 | (Bq9) Coronary Ivus |
| Boston Scientific Corporation | $89.21 | 2025 | Avvigo Guidance System |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
| Novo Nordisk INC | $54.79 | 2025 | Wegovy |
| Kestra Medical Technology Services, INC. | $49.89 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $41.11 | 2024-2025 | Glidewire, Glidesheath Slender, Optitorque |
| Bridgebio Pharma, INC. | $31.68 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $30.30 | 2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $21.85 | 2025 | Amvuttra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $17.56 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Pfizer INC. | $17.05 | 2025 | |
| Merck Sharp & Dohme LLC | $15.64 | 2025 | Verquvo, Capvaxive |
| Scpharmaceuticals INC. | $14.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suraj Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.